High Rates of Recurrent CMV Infection in D+/R- Liver Transplant Recipients with Pre-emptive Therapy

被引：0
|
作者：
Massih, R. Abdel [1 ]
Bogdanovich, T. [1 ]
Carvalho, F.
Minces, L. [1 ]
Kwak, E. [1 ]
Hughes, C. [1 ]
Clancy, C. [1 ]
Nguyen, M. H. [1 ]
Humar, A. [1 ]
Silveira, F. [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA 15260 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2012年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1498
引用
收藏
页码：468 / 469
页数：2
相关论文
共 50 条
  • [41] CMV viral load as predictor for transplant-related mortality in the era of pre-emptive therapy
    Stachel, D.
    Kirby, K.
    Corey, L.
    Boeckh, M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S46 - S46
  • [42] Exploring failure of antimicrobial prophylaxis and pre-emptive therapy for transplant recipients: a systematic review
    Martson, Anne-Grete
    Bakker, Martijn
    Blokzijl, Hans
    Verschuuren, Erik A. M.
    Berger, Stefan P.
    Span, Lambert F. R.
    van der Werf, Tjip S.
    Alffenaar, Jan-Willem C.
    BMJ OPEN, 2020, 10 (01):
  • [43] The devil is in the details: Nuances of pre-emptive therapy for cytomegalovirus disease prevention in high-risk seropositive donors liver transplant recipients
    Heldman, Madeleine R.
    Limaye, Ajit P.
    TRANSPLANT INFECTIOUS DISEASE, 2024, 26 (03)
  • [44] Impact of Cytomegalovirus (CMV) Viral Load on Probability of Spontaneous Clearance and Efficacy of Pre-Emptive Therapy Among CMV Seropositive Allogeneic Stem Cell Transplant Recipients
    Camargo, Jose F.
    Shimose, Luis
    Bueno, Maria X.
    Rosa, Rossana
    Jeyakumar, Nikeshan
    Morris, Michele I.
    Abbo, Lilian M.
    Simkins, Jacques
    Alencar, Maritza C.
    Benjamin, Cara L.
    Wieder, Eric
    Kimble, Erik L.
    Jimenez, Antonio M.
    Beitinjaneh, Amer
    Goodman, Mark
    Byrnes, John J.
    Lekakis, Lazaros
    Pereira, Denise
    Komanduri, Krishna V.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S175 - S176
  • [45] Pre-Emptive Therapy for the Prevention of CMV Infection Post Solid Organ Transplantation: The London Experience
    Atabani, S. F.
    Atkinson, C. E.
    Aldridge, R. W.
    Harber, M.
    Emery, V. C.
    Griffiths, P. D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 456 - 456
  • [46] Pre-emptive oral ganciclovir can reduce the risk of cytomegalovirus disease in liver transplant recipients
    Torre-Cisneros, J
    Madueño, JA
    Herrero, C
    de la Mata, M
    Gonzalez, R
    Rivero, A
    Miño, G
    Sánchez-Guijo, P
    CLINICAL MICROBIOLOGY AND INFECTION, 2002, 8 (12) : 773 - 780
  • [47] Prophylactic Therapy With Valganciclovir in High-Risk (Cytomegalovirus D+/R-) Kidney Transplant Recipients: A Single-Center Experience
    Montejo, M.
    Porto, M.
    Carmon, O.
    Zarraga, S.
    Gainza, J.
    Amenabar, J. J.
    Goikoetxea, J.
    Bereciartua, E.
    Lampreabe, I.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (08) : 2947 - 2949
  • [48] Effect of Prophylaxis Duration on the Incidence of CMV Viremia and Hospitalization Rates in D plus /R- Kidney Transplant Recipients
    Sia, J.
    Westervelt, J.
    Lyden, E.
    Miles, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 211 - 212
  • [49] CMV prophylaxis in high-risk renal transplant patients (D+/R-) by acyclovir with or without hyperimmune (CMV) immunoglobulins: A prospective study
    Rostaing, L
    Martinet, O
    Cisterne, JM
    Icart, J
    Chabannier, MH
    Durand, D
    AMERICAN JOURNAL OF NEPHROLOGY, 1997, 17 (06) : 489 - 494
  • [50] Antigenemia guided ganciclovir therapy in allogeneic BMT recipients: Pre-emptive or early treatment of established CMV disease?
    Machado, CM
    Boas, LSV
    Dulley, FL
    Macedo, MC
    Massumoto, C
    Castelli, JB
    Medeiros, RS
    Silva, RL
    Pannuti, CS
    BLOOD, 1996, 88 (10) : 1684 - 1684
12345